Literature DB >> 7918352

On mixtures of three normal populations caused by monogenic inheritance: application to desipramine metabolism.

K J Miescke1, M N Musa.   

Abstract

For a mixture of three normal distributions, which represent genotypes AA, Aa and aa, a method of estimation of the seven unknown parameters is proposed which works well whenever the phenotype (aa) is sufficiently well separated from the phenotype (AA, Aa). It is based on p-values of Kolmogorov's test of goodness of fit to normality. Initial parameter values for this iterative algorithm can be found by visual check and/or by using the EM algorithm. In an example of a data set of size 59 from a study of the metabolic rate of desipramine, the usefulness of this method is demonstrated. Extensions to more complex situations are feasible and are indicated at the end.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918352      PMCID: PMC1188611     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  4 in total

1.  Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.

Authors:  T K Henthorn; J Benitez; M J Avram; C Martinez; A Llerena; J Cobaleda; T C Krejcie; R D Gibbons
Journal:  Clin Pharmacol Ther       Date:  1989-03       Impact factor: 6.875

2.  A simple method of resolution of a distribution into gaussian components.

Authors:  C G Bhattacharya
Journal:  Biometrics       Date:  1967-03       Impact factor: 2.571

3.  The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.

Authors:  D A Evans; D Harmer; D Y Downham; E J Whibley; J R Idle; J Ritchie; R L Smith
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

4.  Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection.

Authors:  R F Suckow; T B Cooper
Journal:  J Pharm Sci       Date:  1981-03       Impact factor: 3.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.